Nomura Raises PHARMARON TP to HKD32.2 on Higher FY Revenue Forecast Driven by Order BacklogAASTOCKS News·2 days ago, 02:12 AM03759-0.60%300759-1.33%
Pharmaron Unveils 2026 H Share Incentive Plan and Governance OverhaulTip Ranks·Jul 24 at 06:09 AM03759-0.60%300759-1.33%
Pharmaron Beijing files HKEX next-day disclosure return reporting 5,396,470 new H shares issuedPUBT·Jul 22 at 03:40 AM03759-0.60%300759-1.33%
HSBC Research Keeps PHARMARON at Buy, Expects Strong CDMO Growth to Offset FX PressureAASTOCKS News·Jul 15 at 09:40 PM300759-1.33%03759-0.60%
Daiwa Remains a Buy on Pharmaron Beijing Co., Ltd. Class H (17Q1)Tip Ranks·Jul 15 at 07:26 PM300759-1.33%03759-0.60%
UBS' Investment Ratings and TPs on CRO Stocks (Table)AASTOCKS News·Jul 14 at 02:00 AM300759-1.33%02268-1.67%
PHARMARON Expects Interim Net Profit to Rise Up to 10% YoYAASTOCKS News·Jul 13 at 09:16 PM300759-1.33%03759-0.60%
Pharmaron Forecasts Double-Digit Revenue Growth for Interim 2026 ResultsTip Ranks·Jul 13 at 08:08 AM300759-1.33%03759-0.60%
Daiwa Initiates Coverage on PHARMARON With Buy, TP at HKD25.5AASTOCKS News·Jul 7 at 09:50 PM03759-0.60%300759-1.33%
Pharmaron Restructures H Share Awards Amid FX Policy ChangesTip Ranks·Jul 2 at 07:08 AM300759-1.33%03759-0.60%
Pharmaron Shareholders Approve 2025 AGM Resolutions, Dividend Plan and Governance ChangesTip Ranks·Jun 12 at 08:41 AM300759-1.33%03759-0.60%
Pharmaron has continuously received a Wind ESG AA rating, with a comprehensive score of 8.03同壁财经·Jun 2 at 09:10 PM03759-0.60%300759-1.33%
Goldman Sachs Sticks to Its Buy Rating for Pharmaron Beijing Co., Ltd. Class H (17Q1)Tip Ranks·Apr 30 at 08:05 PM03759-0.60%300759-1.33%
BOCI Raises PHARMARON TP to HKD26, Maintains BuyAASTOCKS News·Apr 30 at 03:08 AM300759-1.33%159892+1.53%
Pre-market trend | Pharmaron (3759.HK) is consolidating with reduced volume on April 29, initial bullish signals are emerging, is it building up for a rebound or a trap for the bulls?Technical Forecast·Apr 29 at 08:00 PM03759-0.60%300759-1.33%
